Medication info
Evistra Plus Tablet

Evistra Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Raloxifene Hydrochloride›60mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
Alvogen Korea Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201707350 · Approved 2017.09.29 · Insurance code 652606400

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take this medicine if you require raloxifene therapy and have an inadequate intake of vitamin D. Take 1 tablet orally once daily.

Ingredients

Manufacturer
Alvogen Korea Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat and prevent osteoporosis that can occur in postmenopausal women. Osteoporosis is a disease where the strength of bones weakens, increasing the risk of fractures, particularly common in women after menopause. This drug helps to suppress bone loss and strengthen bones, thereby reducing the risk of fractures. Therefore, it is effective in maintaining bone health and preventing fractures in postmenopausal women.

How to take

Adult dose

Take this medicine if you require raloxifene therapy and have an inadequate intake of vitamin D. Take 1 tablet orally once daily.

Precautions

This medication should be used with caution in patients at risk of thromboembolism, especially if there is a condition that limits mobility, the use of the medication should be discontinued. This drug is not recommended for patients with impaired liver function, and liver function tests should be monitored regularly. It should not be used in premenopausal women as safety has not been established. It is advisable not to use this medication for cardiovascular protection in postmenopausal women with cardiovascular disease or those at high risk. Co-administration with systemic estrogen is not recommended. Women who are pregnant or may become pregnant, and nursing mothers should not take this medication. Patients with a history of thromboembolism, liver disorders, uterine bleeding, endometrial cancer symptoms, and patients with prolonged immobility should not use this medication. Patients with specific genetic metabolic disorders should also avoid this medication. Patients with high blood triglycerides or impaired kidney function, and those with a history of kidney stones should be careful when using this drug. During treatment, side effects such as leg cramps, facial flushing, cold symptoms, peripheral edema may occur; if symptoms are severe, consult a doctor immediately. It is advisable to take supplements if calcium intake is insufficient, and additional vitamin D supplementation may be needed for patients at high risk of vitamin D deficiency. While this medication has minimal specific interactions with other drugs, caution is necessary with certain medications, so inform your doctor of any concurrent medications. As it may harm the fetus during pregnancy, women who are pregnant or planning to become pregnant should avoid taking it, and nursing mothers should also refrain from use for safety. Safety and efficacy in children have not been established; hence it should not be used in pediatric patients. It can be safely used in the elderly, but vitamin D intake should be adjusted for the elderly. In case of overdose, appropriate treatment according to symptoms is necessary, and there is no specific antidote. Store out of reach of children, and it is advisable not to transfer to other containers.

Side effects

Vasodilation (flushing), deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, superficial venous thrombophlebitis, leg cramps, cold symptoms, peripheral edema, decreased platelet count, elevated AST and ALT, cholelithiasis, thrombocytopenia, nausea, vomiting, abdominal pain, dyspepsia, elevated blood pressure, migraine, headache, rash, breast symptoms (pain, swelling, tenderness), arterial thromboembolism, retinal vein occlusion, stroke, death related to deep vein thrombosis, vaginal bleeding, facial edema, heartburn, constipation, itching, palpitations, fever, weakness, sweating, myalgia, insomnia, perineal pain, weight gain, arthritis, rheumatic symptoms, pain, fatigue, discomfort, chest tightness, skin lesions, anxiety, weight loss, seizures, dyspnea, visual disturbances, taste disturbances, mental symptoms, consciousness disturbances, loss of appetite, increased thirst, arrhythmia, increased urinary urgency, kidney stones, renal calcification, calcification of the peripheral tissue of the bone, myalgia, arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.